Basic info
Industry
biotechnology research
Sectors
genetic diseases
Biotechnology
RNA
Liver
vector production
mRNA
drug delivery
base editing
LNP
viral delivery
rare diseases
cell therapy
precision medicines
Genetics
structural biology
immunology
CRISPR
CRISPR Cas9
mRNA Production
protein sciences
nanoparticles formulation
drug development
gene therapy
ex vivo
gene editing
In vivo
lipid nanoparticles
hematology
cell biology
virology
DNA
AAV
Therapeutics
Medical
Cas9
formulation development
Date founded
2017
Funding rounds raised
Total raised
$260M
from 12 investors over 12 rounds
B
Beam Therapeutics raised $260M on January 19, 2021
Investors: Farallon Capital Management, Casdin Capital, LLC, Perceptive Advisors and Redmile Group
B
Beam Therapeutics raised $135M on March 6, 2019
Investors: Omega Funds, F-Prime Capital Partners, Redmile Group, ARCH Venture Partners and GV
B
Beam Therapeutics raised $87M on May 14, 2018
Investors: Osage University Partners (OUP), ARCH Venture Partners and F-Prime Capital Partners